{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:37:49Z","timestamp":1766507869343,"version":"3.48.0"},"reference-count":24,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polish Ministry of Education and Science","award":["643\/WIM"],"award-info":[{"award-number":["643\/WIM"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Antineutrophil cytoplasmic antibody-associated systemic vasculitis (AAV) most often involves the kidneys, upper airways and lungs, and peripheral and central nervous systems (PNS, CNS). However, in contrast to PNS, the involvement of the CNS is rarely taken into account in the recognition and assessment of systemic vasculitis, probably because of nonspecific symptoms such as headaches and dizziness, aphasia, memory disorders, or mood changes. In addition, it is not clear whether treatment of systemic vasculitides reduces cerebral vascular alterations. In this study, we aimed to evaluate the effects of AAV treatment on vascular and vasogenic alterations in the brain in patients with acute vasculitis onset with renal involvement. Methods: Twenty-nine patients (17F, 12M, age 60.4 \u00b1 9.8) with AAV relapse with renal involvement were included in the study. The initial baseline assessment and the second evaluation, performed 12.6 \u00b1 2.5 months after the beginning of immunosuppressive treatment, included clinical, neurological, and renal function assessments, along with a brain MRI. Results: Compared with baseline, improvement in clinical, neurological, and renal function was observed during the second clinical evaluation. A significant reduction in the occurrence of vascular dilatation and narrowing in secondary (37.9% vs. 17.2%; p = 0.031) and tertiary (37.9% vs. 10.3%; p = 0.008) cerebral vascular branches was observed. However, the number of vasogenic cerebral white matter lesions detected on the FLAIR sequence increased significantly (36.0 vs. 48.0%; p &lt; 0.001). Conclusions: Intensive immunosuppressive treatment of acute-onset systemic AAV with renal involvement decreases disease activity, improves kidney function, and decreases central nervous system vascular but not vasogenic alterations.<\/jats:p>","DOI":"10.3390\/jcm15010058","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:27:47Z","timestamp":1766500067000},"page":"58","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Treatment Influence on Kidney Function and Brain Non-Contrast MRI Vascular Manifestations of Systemic ANCA-Associated Vasculitis with Renal Involvement"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-4615","authenticated-orcid":false,"given":"Arkadiusz","family":"Lubas","sequence":"first","affiliation":[{"name":"Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Staszewski","sequence":"additional","affiliation":[{"name":"Department of Neurology, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ksymena","family":"Le\u015bniak","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7999-4196","authenticated-orcid":false,"given":"Grzegorz","family":"Sp\u0142ocharski","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5728-1630","authenticated-orcid":false,"given":"Arkadiusz","family":"Zegad\u0142o","sequence":"additional","affiliation":[{"name":"Department of Radiology, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Maliborski","sequence":"additional","affiliation":[{"name":"Department of Radiology, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0780-3186","authenticated-orcid":false,"given":"Aleksander","family":"D\u0119biec","sequence":"additional","affiliation":[{"name":"Department of Neurology, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8567-7458","authenticated-orcid":false,"given":"Julia","family":"Bry\u0142owska","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Warsaw, 02-089 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tymoteusz","family":"Lubas","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Gda\u0144sk, 80-210 Gda\u0144sk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-860X","authenticated-orcid":false,"given":"Stanis\u0142aw","family":"Niemczyk","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine\u2014National Research Institute, 04-141 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Almaani, S., Fussner, L.A., Brodsky, S., Meara, A.S., and Jayne, D. (2021). ANCA-Associated Vasculitis: An Update. J. Clin. Med., 10.","DOI":"10.3390\/jcm10071446"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lubas, A., Staszewski, J., Maliborski, A., Mosakowska, M., Sp\u0142ocharski, G., Bilbin-Bukowska, A., Wo\u0142oszy\u0144ska, I., Piusi\u0144ska-Macoch, R., Pa\u0142ka, D., and Zegad\u0142o, A. (2022). Vascular and Vasogenic Manifestations of Systemic ANCA-Associated Vasculitis with Renal Involvement in Non-Contrast Brain MRI in Patients with Acute Disease Onset. J. Clin. Med., 11.","DOI":"10.3390\/jcm11164863"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s10067-020-04975-y","article-title":"Central Nervous System Involvement in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 29 Cases in a Single Chinese Center","volume":"39","author":"Ma","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_4","first-page":"e14205","article-title":"From Kidney to Brain: An Uncommon Severe Relapse of Myeloperoxidase Antineutrophil Cytoplasmic Antibody (MPO-ANCA) Vasculitis","volume":"13","author":"Maia","year":"2021","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"152751","DOI":"10.1016\/j.semarthrit.2025.152751","article-title":"Nervous System Involvement in ANCA-Associated Vasculitis: Single Center Experience from Latin America","volume":"73","year":"2025","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"sfae389","DOI":"10.1093\/ckj\/sfae389","article-title":"Top Ten Tips in Managing ANCA Vasculitis","volume":"18","author":"Tan","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/CM9.0000000000003574","article-title":"Inflammatory Disorders That Affect the Cerebral Small Vessels","volume":"138","author":"Han","year":"2025","journal-title":"Chin. Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"A Disease-Specific Activity Index for Wegener\u2019s Granulomatosis: Modification of the Birmingham Vasculitis Activity Score","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_10","unstructured":"ICHD-3 (2025, November 10). The International Classification of Headache Disorders. Available online: https:\/\/ichd-3.org\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/j.sult.2020.02.004","article-title":"CNS Vasculitis\u2014An Overview of This Multiple Sclerosis Mimic: Clinical and MRI Implications","volume":"41","author":"Jewells","year":"2020","journal-title":"Semin. Ultrasound CT MRI"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3174\/ajnr.A5300","article-title":"Concordance of Time-of-Flight MRA and Digital Subtraction Angiography in Adult Primary Central Nervous System Vasculitis","volume":"38","author":"Boulouis","year":"2017","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","article-title":"KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis","volume":"105","author":"Floege","year":"2024","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis with Polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13244-024-01710-y","article-title":"Temporal Evolution of Primary Angiitis of the Central Nervous System (PACNS) on MRI Following Immunosuppressant Treatment","volume":"15","author":"Wagner","year":"2024","journal-title":"Insights Imaging"},{"key":"ref_18","first-page":"811","article-title":"Serial Vessel Wall Enhancement Pattern on High-Resolution Vessel Wall Magnetic Resonance Imaging and Clinical Implications in Patients with Central Nervous System Vasculitis","volume":"40","author":"Shimoyama","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_19","unstructured":"Sharma, R., Sekhon, S., Lui, F., and Cascella, M. (2024). White Matter Lesions. Encyclopedia of Gerontology and Population Aging, Springer."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/cjn.2021.249","article-title":"Breakthrough of Granulomatosis with Polyangiitis-Associated CNS Vasculitis Amidst Adequate B-Cell Depletion","volume":"50","author":"Rivet","year":"2023","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00415-009-5008-7","article-title":"Effects of Statins on the Progression of Cerebral White Matter Lesion: Post Hoc Analysis of the ROCAS (Regression of Cerebral Artery Stenosis) Study","volume":"256","author":"Mok","year":"2009","journal-title":"J. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Camard, M., Moises, A., Bourdic, K., Venditti, L., Denier, C., Henry, J., Sterpu, R., David, P., De Menthon, M., and Lambotte, O. (2025). Cognitive Impairment in ANCA-Associated Vasculitis: A Cross-Sectional Pilot Study. J. Clin. Med., 14.","DOI":"10.3390\/jcm14103582"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR Recommendations for the Management of ANCA-Associated Vasculitis: 2022 Update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/head.14683","article-title":"Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Headache and Stroke as the Main Symptoms: A Case Report","volume":"64","author":"Wu","year":"2024","journal-title":"Headache J. Head Face Pain"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/58\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:47:34Z","timestamp":1766501254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010058"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010058","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}